目的:观察清肺祛瘀汤对放射性肺炎的治疗作用.方法:将60例放射性肺炎患者随机分为两组,治疗组30例,对照组30例,对照组均予肾上腺皮质激素、头孢唑酮钠加舒巴坦钠治疗,治疗组在此基础上加用清肺祛瘀汤治疗,应用 Leicester咳嗽问卷、激素应用时间、CT变化评价疗效.结果:Leicester咳嗽问卷评分显示,两组治疗后生理状况、心理健康、社会功能三方面均较治疗前明显好转(P<0.05),并且治疗组在心理健康及总分上较对照组改善显著(P<0.05).观察组胸部CT变化改善率明显优于对照组(P<0.05).观察治疗组症状缓解时激素使用时间均明显短于对照组,两组比较有显著性意义(P<0.05).结论:在西药基础上加用清肺祛瘀汤可有效治疗放射性肺炎,缓解咳嗽症状,提高患者生活质量.

目的:观察清肺祛瘀汤对放射性肺损伤的治疗作用及相关细胞因子的影响.方法:将60例患者随机分为清肺祛瘀汤合激素抗生素组30例,单纯激素抗生素组30例,治疗前后观察中医症状、CT疗效、检测血浆TNFα、IL-6.结果:治疗后,治疗组中医症状疗效改善明显优于对照组；2组治疗后TNF-α、IL-6水平均低于治疗前.结论:清肺祛瘀汤可有效改善放射性肺损伤咳嗽症状,抑制放疗后血浆TNF-α、IL-6的过度表达,对放射性肺损伤具有保护作用.

Objective:To study the relationship between the expression of MMP9 and the overexpression of C-erbB-2 in breast cancer.Methods:To detect the expression of MMP9 and C-erbB-2 in 120 specimens of breast cancer patients by the way of IHC.Results:The positive rate of MMP9 in 120 tumor specimens was 75(62.5%),positive rate of C-erbB-2 was 44(36.7%).The positive expression of MMP9 was correlated with overexpression of C-erbB-2 in breast cancer.Conclusion:There is a significant correlation between the expression of MMP9 and C-erbB-2 in breast carcinoma.They are both the prognotic factors in breast cancer.

我国现有癌症患者200万,疼痛发生率40%～50%,其中25%的病人未得到治疗,中、重度疼痛占20%.癌症疼痛的控制对护理工作提出更高的要求,我科根据病人特点从知、信、行三方面进行癌痛病人健康教育,取得较好效果.